期刊文献+

泌尿系结石患者尿路大肠埃希菌感染的临床特点及药物敏感性分析 被引量:16

Antibiotic susceptibility and clinical characteristics of Escherichia coli in patients with urinary tract stones
下载PDF
导出
摘要 目的分析泌尿系结石患者尿路大肠埃希菌感染的临床特点及药物敏感性情况,为临床合理用药提供参考。方法回顾性分析广州医科大学附属第一医院泌尿外科2010年1月-2015年12月泌尿系结石患者中段尿培养分离的大肠埃希菌对常见抗菌药物敏感性的结果。结果泌尿系结石合并尿路大肠埃希菌感染的患者共1 894例。其中,男性患者555例(29.30%),平均年龄54.05岁,女性患者1 339例(70.70%),平均年龄53.24岁。41~60岁年龄段的男、女性患者比例最大,分别占41.34%和55.82%。大肠埃希菌对头孢美唑、头孢替坦、丁胺卡那霉素、替加环素、哌拉西林/他唑巴坦以及碳青霉烯类(厄他培南、美罗培南、亚胺培南)等抗菌药物的敏感性高于90%以上;对氨苄西林、头孢唑啉、头孢噻肟、头孢曲松、左氧氟沙星、环丙沙星等抗菌药物的敏感性低于40%。结论泌尿系结石患者尿路大肠埃希菌对喹诺酮类及部分第3代头孢菌素类抗菌药物的敏感性较低,不适合用于经验性治疗;而对头孢美唑、头孢替坦、哌拉西林/他唑巴坦以及碳青霉烯类等抗菌药物则较为敏感,临床治疗中需根据药敏结果进行规范用药。 Objective To investigate the antibiotic susceptibility and clinical characteristics of Escherichia coli isolated from urine specimens in patients with urinary calculi.Methods The results of antibiotic susceptibility of Escherichia coli isolated from mid-stream urine of the patients with urinary calculi in the First Affiliated Hospital of Guangzhou Medical University between January 2010 and December 2015 were analyzed retrospectively.Results A total of 1,894 strains of Escherichia coli were detected from urine specimens in the patients with urinary calculi,including 555(29.30%)from male and 1,339(70.70%)from female.Among them,the most common age group was 41-60 years both in male(41.34%)and female(55.82%).Escherichia coli was sensitive to Cefmetazole,Cefotetan,Amikacin,Tigecycline,Piperacillin/Tazobactam and Carbapenems(including Ertapenem,Meropenem and Imipenem),and the sensitive rates were all more than 90%.In contrast,it was less sensitive to antibiotics such as Ampicillin,Cefazolin,Cefotaxime,Ceftriaxone,Levofloxacin and Ciprofloxacin,with the sensitive rate less than 40%.Conclusions Escherichia coli from the urine of the patients with urinary calculi showed low sensitive rate to Fluoroquinolones and some of the third-generation Cephalosporins,which may not be suitable for empirical therapy in the patients with urinary calculi.In contrast,the bacteria is sensitive to Cefmetazole,Cefotetan,Piperacillin/Tazobactam and Carbapenems.In the treatment of urinary tract infection in the patients with urinary calculi,standardized medication should be taken according the antibiotic sensitivity.
作者 张玉艳 蓝创歆 陈东 刘艳红 黄健 曾滔 龙惠 吴文起 Yu-yan Zhang;Chuang-xin Lan;Dong Chen;Yan-hong Liu;Jian Huang;Tao Zeng;Hui Long;Wen-qi Wu(Department of Pharmacy,Guangzhou Institute of Dermatology,Guangzhou,Guangdong 510095,China;Department of Urology,the First Affiliated Hospital of Guangzhou Medical University,Guangzhou,Guangdong 510230,China)
出处 《中国现代医学杂志》 CAS 2018年第10期94-98,共5页 China Journal of Modern Medicine
基金 广州市科技计划项目(No:201604020001)
关键词 泌尿系结石 尿路感染 大肠埃希菌 药物敏感性 urinary calculus urinary tract infection Escherichia coli drug sensitivity
  • 相关文献

参考文献6

二级参考文献42

  • 1黄锦坤,李逊,吴开俊,罗金泰.复杂性肾结石感染的菌谱、耐药谱分析[J].中国医药,2006,1(2):110-112. 被引量:9
  • 2何国伟,林锦德.佛山地区1063例尿石症分析[J].实用医学杂志,1996,12(12):802-803. 被引量:8
  • 3安玉梅.乌兰察布市泌尿系统结石病的流行病学调查[J].临床和实验医学杂志,2007,6(3):168-169. 被引量:11
  • 4[1]Sambrook J. Fritsch E F, Maniatis T. Molecular cloning A Laboratory Manual[M]. 2nd ed. Cold Spring Harbor Laboratory Press, 1989. 21-52.
  • 5[3]Amyes SGB, Gemmell CG, Antibotic resistance in bacteria[J]. J Med Microbiol, 1992, 36:4.
  • 6Clinical and Laboratory Standards Institute/NCCLS.Performance standards for antimicrobial susceptibility testing; Fifteenth informational supplement. CLSI/NCCLS document M100-S15.Clinical and Laboratory Standards Institute,Wayne,Pennsylvania,2005,25 (1):1-167.
  • 7Zanetti G,Paparella S,Trinchieri A,et al.Infections and urolithiasis:current clinical evidence in prophylaxis and antibiotic therapy.Arch Ital Urol Androl,2008,80(1):5-12.
  • 8Miano R,Germani S,Vespasiani G.Stones and urinary tract infections.Urol Int,2007,79Suppl(1):32-36.
  • 9Thomas B,Tolley D.Concurrent urinary tract infection and stone disease:pathogenesis,diagnosis and management.Nat Clin Pract Urol,2008,5 (12):668-675.
  • 10Sohshang HL,Singh MA,Singh NG.et al.Biochemical and bacteriological study of urinary calculi.J Commun Dis,2000,32(3):216-221.

共引文献303

同被引文献144

引证文献16

二级引证文献85

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部